481 filings
Page 20 of 25
8-K
6dn9b8xwe4ixq
7 May 19
BioXcel Therapeutics Reports First Quarter 2019 Results and Provides Business Update
8:17am
EFFECT
otebj
5 Apr 19
Notice of effectiveness
12:16am
UPLOAD
w7mlb
4 Apr 19
Letter from SEC
12:00am
DEFA14A
zi50og9
2 Apr 19
Additional proxy soliciting materials
12:00am
CORRESP
659pcziblm75wpt f7e
2 Apr 19
Correspondence with SEC
12:00am
DEF 14A
q45xs2e ew8kt
1 Apr 19
Definitive proxy
5:20pm
RW
cdsbcp2ycq9jo0y8
1 Apr 19
Registration withdrawal request
5:15pm
8-K
g1eqt85
1 Apr 19
BioXcel Therapeutics Showcases Data on BXCL701 in Combination with OX40 Agonist in Late-breaking Poster Presentation at AACR Annual Meeting
4:08pm
8-K
w36itph9h7cgox pco3
25 Mar 19
Other Events
4:45pm
4
txbkl61f1n3sq2zxw9i
18 Mar 19
BioXcel Therapeutics / Michal Votruba ownership change
5:38pm
3
vcqhthgcd qcm
18 Mar 19
BioXcel Therapeutics / Michal Votruba ownership change
5:35pm
S-3
muv06f
14 Mar 19
Shelf registration
4:45pm
8-K
2mlst 9ro
12 Mar 19
Other Events
5:21pm
10-K
6rjbh6
12 Mar 19
Annual report
12:00am
8-K
ml87ygj s5c2f8
11 Mar 19
BioXcel Therapeutics Announces Late Breaking Data Presentation at AACR 2019 Annual Meeting
4:38pm
8-K
kxhur43fe60r7fz
7 Mar 19
BioXcel Therapeutics Reports Fourth Quarter and Full Year 2018 Quarterly Results and Provides Business Update
4:42pm
8-K
zkig1ghl8m6
4 Mar 19
Other Events
4:19pm
SC 13G
7f1sinm4uh
14 Feb 19
BioXcel Therapeutics, Inc.
7:33am